Midatech Pharma Announced R&D Collaboration with Janssen on Second Molecule –
Midatech Pharma PLC (AIM: MTPH; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce an extension of its existing R&D collaboration with Janssen Pharmaceutica NV (Janssen) originally announced on 21 July 2020.
EPO Site Shows Midatech Pharma Granted Patent ‘DEVICE AND METHOD FOR PRODUCING AND COLLECTING BEADS.’
https://register.epo.org/application?number=EP12754064
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.
22 Stocks Moving in Monday’s Pre-Market Session
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday.
Midatech Pharma PLC Announced IND Application for MTX110 Study in GBM Effective
Midatech Pharma PLC (AIM:MTPH)(NASDAQ: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that its Investigational New Drug (IND) application for a Phase 1 study of MTX110, a panobinostat complex to be administered by convection enhanced delive
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Dermata Therapeutics (NASDAQ:DRMA) stock increased by 28.63% to $5.66 during Monday's after-market session. The market value of their outstanding shares is at $47.1 million.
